Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Panbela Therapeutics, Inc. (PBLA)  
$6.87 0.00 (0.00%) as of 4:30 Fri 1/19


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 9,650,000
Market Cap: 66.30(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4338 - $7.13
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year    
 
Company Profile   Panbela Therapeutics is a clinical stage biopharmaceutical company developing therapeutics for the treatment of patients with cancer. Co.'s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition, a metabolic pathway of critical importance in multiple tumor types.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 406,888
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 5
Total Buy Transactions 0 0 0 5
Total Shares Sold 0 0 72,874 72,874
Total Sell Value $0 $0 $51,741 $51,741
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 1 1
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 78
  Page 4 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Schaffer Paul W. Director   –       •      –    2015-09-04 3 IO $0.00 $0 D/D 0 894,204     -
   Sargent Robert John   –       •       •   2015-03-16 4 B $0.10 $10,006 I/I 100,060 100,060 0.01     -
   Fuhrman David Michael President and CEO   •       •       •   2015-03-16 4 B $0.10 $10,006 D/D 100,060 100,060 0.01     -

  78 Records found
  1  2  3  4    
  Page 4 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed